Shionogi
Shionogi is a global research-driven pharmaceutical company dedicated to shaping the future of healthcare through innovative solutions and partnerships. With a strong focus on infectious diseases and unmet clinical needs, it strives to deliver high-quality medicines and contribute to society by addressing health challenges and supporting sustainable development goals.
Industries
Nr. of Employees
Very Large (1000+)
Shionogi
Herengracht 464, 1017 CA, Amsterdam, the Netherlands
Patents
Products
Antibiotics
Shionogi developed an antibiotic targeting multidrug resistant Gram-negative bacteria, addressing a major global public health concern.
HIV Therapy
As part of ViiV Healthcare, Shionogi developed two significant HIV medications in the last decade.
Influenza Treatment and Prevention
Shionogi discovered an antiviral drug for treating and preventing influenza virus infections.
COVID-19
Shionogi is focused on addressing challenges posed by COVID-19 as part of its commitment to combating infectious diseases.
Serious Fungal Infection
Shionogi is working on antifungal agents to address unmet needs caused by drug-resistant aspergillus and other rare mould infections.
Women's Health
Shionogi developed a therapy for vulvar and vaginal atrophy, a condition occurring post-menopause.
Antibiotics
Shionogi developed an antibiotic targeting multidrug resistant Gram-negative bacteria, addressing a major global public health concern.
HIV Therapy
As part of ViiV Healthcare, Shionogi developed two significant HIV medications in the last decade.
Influenza Treatment and Prevention
Shionogi discovered an antiviral drug for treating and preventing influenza virus infections.
COVID-19
Shionogi is focused on addressing challenges posed by COVID-19 as part of its commitment to combating infectious diseases.
Serious Fungal Infection
Shionogi is working on antifungal agents to address unmet needs caused by drug-resistant aspergillus and other rare mould infections.
Women's Health
Shionogi developed a therapy for vulvar and vaginal atrophy, a condition occurring post-menopause.
Services
GLP-compliant testing for agricultural production materials, including pesticide efficacy, residue analysis, and ecotoxicity studies.
Design and execution of small-plot screens, greenhouse tests, field trials (rice paddies, tea, orchards) and specialized soil-model plots.
Provision of medical information to healthcare professionals and patients and mechanisms to receive and process adverse event reports.
Post-marketing safety monitoring and related pharmacovigilance activities to manage product safety throughout the lifecycle.
Contracted experimental research support across preclinical and applied research programs.
Monitoring and analytical services for epidemiological components in environmental matrices such as sewage to support surveillance and data-driven decisions.
GLP-compliant testing for agricultural production materials, including pesticide efficacy, residue analysis, and ecotoxicity studies.
Design and execution of small-plot screens, greenhouse tests, field trials (rice paddies, tea, orchards) and specialized soil-model plots.
Provision of medical information to healthcare professionals and patients and mechanisms to receive and process adverse event reports.
Post-marketing safety monitoring and related pharmacovigilance activities to manage product safety throughout the lifecycle.
Contracted experimental research support across preclinical and applied research programs.
Monitoring and analytical services for epidemiological components in environmental matrices such as sewage to support surveillance and data-driven decisions.
Expertise Areas
- Drug discovery and development
- Antimicrobial drug development
- Vaccine development
- Pharmaceutical manufacturing and engineering
Key Technologies
- GLP testing frameworks
- Field agronomic trial design
- Controlled-environment (greenhouse) studies
- Artificial rainfall and environmental simulation
News & Updates
Visit the press release section for the latest updates and contact the Press Office for media inquiries.
In 2023, Shionogi & Co., Ltd. was recognized for leadership in corporate transparency and performance on climate and water security.
Visit the press release section for the latest updates and contact the Press Office for media inquiries.
In 2023, Shionogi & Co., Ltd. was recognized for leadership in corporate transparency and performance on climate and water security.